1) The study examined 100 autopsied livers containing metastatic cancers and found that metastases were most commonly of the multinodular type (65%).
2) Metastases from colon and lung cancers most often showed intraparenchymal growth within the liver tissue (92.3% and 87.5%, respectively), while metastases from gallbladder/bile duct cancer less frequently showed intraparenchymal growth (35.7%).
3) Micrometastases under 1mm from lung, colon, and pancreas cancers predominantly displayed a replacement growth pattern, replacing hepatocytes. Micrometastases from stomach and gallbladder/bile duct cancers predominantly showed a sinusoidal growth pattern within liver
Gastric neuroendocrine carcinomas are rare and have a poor prognosis. The present case concerns with a 55 year old female who presented with complaints of recurrent vomiting on and off, hematemesis and weight loss and history of lumbar stenosis. Esophagogastroduedenostomy (EGD) showed a large ulcerated growth in the antrum. Computed tomography abdomen revealed an ill defined soft tissue density in the gastric antrum, a partial gastrectomy was performed. Microscopic evaluation revealed a neuroendocrine neoplasm. Immunohistochemically positive for Chromogranin A and Non Specific Enolase (NSE). A diagnosis of Neuroendocrine carcinoma of the stomach was given based on recent WHO classification of Neuroendocrine carcinoma of the stomach and on mitotic index with reference to grading scale.
Adjuvant therapy protocols for liver cancer in patients undergoing liver tran...hr77
Many patients undergo liver transplantation for a liver cancer in a setting of liver cirrhosis. When is it possible to consider chemotherapy in such patients? Is it even possible? Is there a role?
Gastric neuroendocrine carcinomas are rare and have a poor prognosis. The present case concerns with a 55 year old female who presented with complaints of recurrent vomiting on and off, hematemesis and weight loss and history of lumbar stenosis. Esophagogastroduedenostomy (EGD) showed a large ulcerated growth in the antrum. Computed tomography abdomen revealed an ill defined soft tissue density in the gastric antrum, a partial gastrectomy was performed. Microscopic evaluation revealed a neuroendocrine neoplasm. Immunohistochemically positive for Chromogranin A and Non Specific Enolase (NSE). A diagnosis of Neuroendocrine carcinoma of the stomach was given based on recent WHO classification of Neuroendocrine carcinoma of the stomach and on mitotic index with reference to grading scale.
Adjuvant therapy protocols for liver cancer in patients undergoing liver tran...hr77
Many patients undergo liver transplantation for a liver cancer in a setting of liver cirrhosis. When is it possible to consider chemotherapy in such patients? Is it even possible? Is there a role?
Prevalence of Gallbladder Cancer in Arsenic Endemic Areas-Crimson PublishersCrimsonpublishersCancer
Association between exposure to high arsenic content and gallbladder cancer is scanty. Few reports suggest that the incidence of gallbladder cancer is high along the Indo-Gangetic belt. Inflammation, which is a causative factor for gallbladder carcinoma can be induced by arsenic. Prognosis of gallbladder cancer is poor. Therefore, it is worthwhile to find a correlation between arsenic exposure and its incidence to identify a population who are at high risk category.
Cholangiocarcinoma: Pathology, diagnosis and treatment.Marco Castillo
A brief description with many abdominal imaging of the Cholangiocarcinoma.
Includes definition, epidemiology, pathology, classification, clinical presentation, diagnosis, staging and treatment.
ABSTRACT- Introduction- Gall bladder carcinoma is the most frequent carcinoma of the biliary tract. Pure mucinous adenocarcinoma as seen in breast, skin, and pancreas are very uncommon in the gall bladder. Mucinous adenocarcinoma of gall bladder is rarer variant of gall bladder carcinoma.
Methods- We were reported a case of 55 years old male presenting at department of surgery of LLR and Associated Hospital with nonspecific symptoms of diffuse pain abdomen with nausea and vomiting, generalized weakness, itching all over body, jaundice associated with anorexia and weight loss for last 4 to 5 months, ultrasonography revealed gross thickening of wall of gall bladder neck with ill define mass lesion and diagnosis was confirmed by USG guided FNAC, Histopathological examination and Immunohistochemistry (IHC).
RESULTS- Patient present with pain abdomen, icterus and anorexia, on USG guided FNAC cytological and Histopathological findings are suggestive of mucinous adenocarcinoma.
Conclusion- Mucinous adenocarcinoma is the rarest variant of adenocarcinoma gallbladder. Incidental diagnosis of mucinous adenocarcinoma of gall bladder was found by USG guided FNAC followed by the histopathological examination.
Key-words- Mucinous Adenocarcinoma, Gall bladder, FNAC, Mucin
Molecular characterization of a patient’s tumor to guide treatment decisions is increasingly being
applied in clinical care and can have a significant impact on disease outcome. These molecular analyses,
including mutation characterization, are typically performed on tissue acquired through a biopsy at diagnosis.
However, tumors are highly heterogeneous and sampling in its entirety is challenging. Furthermore, tumors
evolve over time and can alter their molecular genotype, making clinical decisions based on historical biopsy
data suboptimal. Personalized medicine for cancer patients aims to tailor the best treatment options for the
individual at diagnosis and during treatment. To fully enable personalized medicine it is desirable to have an
easily accessible, minimally invasive way to determine and follow the molecular makeup of a patient’s tumor
longitudinally. One such approach is through a liquid biopsy, where the genetic makeup of the tumor can be
assessed through a bio fluid sample. Liquid biopsies have the potential to help clinicians screen for disease,
stratify patients to the best treatment and monitor treatment response and resistance mechanisms in the tumor. A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature
allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. This review will summarize three approaches in the liquid biopsy field: circulating tumor cells (CTCs), cell free DNA (cfDNA) and exosomes. We also outline some of the analytical challenges encountered using liquid biopsy techniques to detect rare mutations in a background of wild-type sequences.
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...Gastrolearning
Gastrolearning II modulo/8a lezione
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento
Prof. D. Alvaro - Università di Roma La Sapienza
Abstract
Metastatic gastric tumors (MGTs) mean the tumor cells that attack the stomach and grow there through blood vessel, lymph vessel, and other pathway, consistent with the primary tumor in phenotype, which are clinically uncommon, and information on MGTs is generally limited to single case reports. Here we present a clinical series of 8 cases with MGTs, in attention to discuss the clinical characteristics, diagnosis and treatment, and prognosis of MGTs. Our data showed that MGTs are rare, with a male predominance, and the cause of death was multiple organ metastases in most cases. Heterochromous MGTs showed a significantly better prognosis than simultaneous MGTs, and a long interval between initial radical excision of the primary tumor and appearance of gastric metastasis was found to be associated with good prognosis.
Prevalence of Gallbladder Cancer in Arsenic Endemic Areas-Crimson PublishersCrimsonpublishersCancer
Association between exposure to high arsenic content and gallbladder cancer is scanty. Few reports suggest that the incidence of gallbladder cancer is high along the Indo-Gangetic belt. Inflammation, which is a causative factor for gallbladder carcinoma can be induced by arsenic. Prognosis of gallbladder cancer is poor. Therefore, it is worthwhile to find a correlation between arsenic exposure and its incidence to identify a population who are at high risk category.
Cholangiocarcinoma: Pathology, diagnosis and treatment.Marco Castillo
A brief description with many abdominal imaging of the Cholangiocarcinoma.
Includes definition, epidemiology, pathology, classification, clinical presentation, diagnosis, staging and treatment.
ABSTRACT- Introduction- Gall bladder carcinoma is the most frequent carcinoma of the biliary tract. Pure mucinous adenocarcinoma as seen in breast, skin, and pancreas are very uncommon in the gall bladder. Mucinous adenocarcinoma of gall bladder is rarer variant of gall bladder carcinoma.
Methods- We were reported a case of 55 years old male presenting at department of surgery of LLR and Associated Hospital with nonspecific symptoms of diffuse pain abdomen with nausea and vomiting, generalized weakness, itching all over body, jaundice associated with anorexia and weight loss for last 4 to 5 months, ultrasonography revealed gross thickening of wall of gall bladder neck with ill define mass lesion and diagnosis was confirmed by USG guided FNAC, Histopathological examination and Immunohistochemistry (IHC).
RESULTS- Patient present with pain abdomen, icterus and anorexia, on USG guided FNAC cytological and Histopathological findings are suggestive of mucinous adenocarcinoma.
Conclusion- Mucinous adenocarcinoma is the rarest variant of adenocarcinoma gallbladder. Incidental diagnosis of mucinous adenocarcinoma of gall bladder was found by USG guided FNAC followed by the histopathological examination.
Key-words- Mucinous Adenocarcinoma, Gall bladder, FNAC, Mucin
Molecular characterization of a patient’s tumor to guide treatment decisions is increasingly being
applied in clinical care and can have a significant impact on disease outcome. These molecular analyses,
including mutation characterization, are typically performed on tissue acquired through a biopsy at diagnosis.
However, tumors are highly heterogeneous and sampling in its entirety is challenging. Furthermore, tumors
evolve over time and can alter their molecular genotype, making clinical decisions based on historical biopsy
data suboptimal. Personalized medicine for cancer patients aims to tailor the best treatment options for the
individual at diagnosis and during treatment. To fully enable personalized medicine it is desirable to have an
easily accessible, minimally invasive way to determine and follow the molecular makeup of a patient’s tumor
longitudinally. One such approach is through a liquid biopsy, where the genetic makeup of the tumor can be
assessed through a bio fluid sample. Liquid biopsies have the potential to help clinicians screen for disease,
stratify patients to the best treatment and monitor treatment response and resistance mechanisms in the tumor. A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature
allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. This review will summarize three approaches in the liquid biopsy field: circulating tumor cells (CTCs), cell free DNA (cfDNA) and exosomes. We also outline some of the analytical challenges encountered using liquid biopsy techniques to detect rare mutations in a background of wild-type sequences.
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...Gastrolearning
Gastrolearning II modulo/8a lezione
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento
Prof. D. Alvaro - Università di Roma La Sapienza
Abstract
Metastatic gastric tumors (MGTs) mean the tumor cells that attack the stomach and grow there through blood vessel, lymph vessel, and other pathway, consistent with the primary tumor in phenotype, which are clinically uncommon, and information on MGTs is generally limited to single case reports. Here we present a clinical series of 8 cases with MGTs, in attention to discuss the clinical characteristics, diagnosis and treatment, and prognosis of MGTs. Our data showed that MGTs are rare, with a male predominance, and the cause of death was multiple organ metastases in most cases. Heterochromous MGTs showed a significantly better prognosis than simultaneous MGTs, and a long interval between initial radical excision of the primary tumor and appearance of gastric metastasis was found to be associated with good prognosis.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Gallbladder carcinoma is fifth most common gastrointestinal malignancy. Main indication for cholecystectomy is gallstone disease. Majority of gallbladder carcinomas are diagnosed during the course of histopathological evaluation of specimens obtained at cholecystectomy. Accomplishing radical cholecystectomy is advisable in these patients. Technically difficult gallbladder dissection during the course of laparoscopic surgery should raise a high suspicion of malignancy. Specimen retrieval bags should be used in all cases to avoid external spillage of bile giving rise to port side metastasis. A good outcome depends on prompt diagnosis and radical surgical resection. It is essential for a general surgeon to be aware of predisposing factors, pathology, patterns of presentation, and surgical options in gallbladder carcinoma.
Nowadays the problem of surgical treatment of Colorectal
Cancer (CRC) is becoming very important due to the high speed of increasing morbidity and mortality, which is registered almost in all economically developed countries in the world [1,2]. In 2012, more than one million new cases of CRC were detected on our planet and about half a million people died from this disease [1]. On the territory of Russia, a primary diagnosis of colorectal cancer is annually established in 6000 people, with the highest incidence rates in the North-West region (St. Petersburg and Leningrad region), where in the general structure of oncopathology, colorectal cancer is in the second
Co-Existent Primary Choriocarcinoma and Adenocarcinoma in the StomachApollo Hospitals
Choriocarcinoma is an intrauterine and gestational related invasive tumour. Primary choriocarcinoma in parenchymal organ specially in gastrointestinal tract are rare. A case of Primary Gastric Choriocarcinoma (PGC) associated with adenocarcinoma in a 27 years old woman is being reported.
Analysis of Treatment Option for Synchronous Liver Metastases and Colon Recta...daranisaha
Colorectal or bowel cancer is one of the major cause of cancer worldwide. Research has shown that 15 to 20 % colorectal cancer patients are also diagnosed with synchronous liver metastases (LM) at presentation and about one third eventually develop liver lesions (Leporrier, Maurel, Chiche, Bara, Segol, and Launoy, 2006; Manfredi, Lepage, Hatem, Coatmeur, Faivre, and Bou-vier, 2006)...
Similar to Histologic Growth Patterns of Metastatic Carcinomas of the Liver (20)
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Multi-source connectivity as the driver of solar wind variability in the heli...
Histologic Growth Patterns of Metastatic Carcinomas of the Liver
1. Histologic Growth Patterns of Metastatic Carcinomas of the Liver
Noboru Terayama, Tadashi Terada and Yasuni Nakanuma
Second Department of Pathology, Kanazawa University School of Medicine, Kanazawa
One hundred autopsied livers containing metastatic cancers were studied patholgically. Macro-
scopically, the cancers were of the multinodular type in 65.0% of cases, massive type in 17.0%
and portal tract type in 8.0%. Among liver metastases from colon and lung cancers, most cases
showed predominantly intraparenchymal growth (92.3% and 87.5%, respectively). In contrast,
among liver metastases from gallbladder/bile duct cancer, intraparenchymal growth was less fre-
quent (35.7%). With regard to the histologic growth pattern at the boundary of the liver
metastases, in micrometastases less than 1 mm in diameter a replacement growth pattern was
predominant among metastases from lung, colon and pancreas cancers (69.7%, 79.3% and
66.7%, respectively), whereas a sinusoidal growth pattern was predominant in those from gas-
tric and gallbladder/bile duct cancers (48.5% and 66.7%). Among macrometastases of the liver
over 20 mm in diameter, an expansive growth pattern was predominant, irrespective of the
cancer primary site. Thus metastatic liver cancers showed changes in growth patterns accord-
ing to the size of the metastatic tumors.
(Jpn J Clin Oncol 26: 24-29, 1996)
Key words: Liver—Metastasis—Pathology
Introduction
Many malignant neoplasms often metastasize to
the liver, and the frequency of liver metastasis is
much higher than that of primary liver cancers.1
'
Eggel classified primary liver cancer as nodular
type, massive type, or diffuse type according to its
gross appearance.2
' The histologic patterns of
tumor growth of hepatocellular carcinoma at
tumor-non-tumor boundaries were described by
Nakashima et al.3)
as follows: sinusoidal pattern,
cancer cells growing in sinusoids at the boundary
and compressing the liver cell cords; replacement
pattern, cancer cells replacing hepatocytes along the
liver cell cords, and the cancer cells adhering to
each other; encapsulated pattern, cancer cells grow-
ing in an expansive manner and acquiring a fibrous
capsule. Certain metastatic cancers in the liver show
sinusoidal growth and a few have surrounding fi-
brous capsules." However, little attention has been
directed toward the replacement growth pattern of
metastatic liver cancer. Furthermore, the difference
Received: May 2, 1995
Accepted: August 16, 1995
For reprints and all correspondence: Yasuni Nakanuma,
Second Department of Pathology, Kanazawa University
School of Medicine, Kanazawa 920
in predominant growth pattern according to the size
of metastatic cancers in the liver has not been ad-
dressed.
Recent progress in diagnostic modalities has made
it possible to analyze the precise morphologic fea-
tures of metastatic liver cancers.4
"6
' In this- study
we investigated the pathology of metastatic liver
cancer to elucidate the histologic differences in in-
dividual primary sites and to correlate the growth
pattern of metastatic liver cancer with the primary
site and the size of the metastatic tumor in order
to improve the interpretation of diagnostic imaging
and the planning of treatment for metastatic liver
cancer.
Materials and Methods
Histologic Specimens
One hundred autopsied livers with metastatic
cancers were studied. The background factors are
summarized in Table I. The patients comprised 71
men and 29 women, with a mean age of 65.7 <
12.3 years. The mean weight of the liver was
1729± 942 g. Cancer primary sites were as follows:
lung 24; pancreas 21; stomach 18; gallbladder/bile
duct 14; colon 13; kidney 3; other cancers 7. There
was no difference in liver weight or patient age
24 Jpn J Clin Oncol 26(1) 1996
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom
2. HISTOLOGIC GROWTH PATTERNS OF LIVER METASTASES
Table I. Main Clinicopathological Features of Autopsy Cases with Liver Metastases
Primary site
Lung
Pancreas
Stomach
GB/Bile duct
Colon
Others
GB, gallbladder: *,
Number of cases
24
21
18
14
13
10
years (mean±SD); f
,
Sex
Male
22
19
15
5
6
4
gram (mean±SD).
Female
2
2
3
9
7
6
Age of patients *
66.3 ±10.1
67.4±10.4
63.3 ±14.9
69.5 ±10.1
63.9±15.0
62.4±12.1
Weight of liver f
1501 ±612
1455 ±377
2099 ±1078
1380 ±245
2317±1539
1996±1015
among the primary sites. Each liver was cut into
1-cm slices and fixed in 10% buffered formalin.
From each liver, we obtained several specimens
containing various sizes of metastatic tumors, and
embedded then in paraffin. Several 5-/mi-thick sec-
tions were obtained from each paraffin-embedded
block and stained with hematoxylin-eosin, Gomori's
reticulin and elastica van Gieson.
Macroscopic Findings
Livers with metastatic tumors were classified by
gross macroscopic appearance in accordance with
Eggel's classification2
' into nodular, massive and
diffuse types. Nodular type was subdivided into
solitary, multinodular and fused types. Livers show-
ing enlarged portal tracts and linear or small nodu-
lar tumors in the vicinity of the portal tracts
considered to be lymphangiosis carcinomatosa7
'8)
were classified as having portal tract-type
metastases.
Microscopic Evaluation
Predominant Sites of Growth: The growth sites of
metastatic liver cancer were classified into two types
according to light microscopic findings: portal tract
growth, metastatic tumors growing within and/or
along the portal tracts; parenchymal growth,
metastatic tumors growing in and/or toward the
hepatic parenchyma with no or little portal tract
growth; intermediate type, including both of the
precious types of growth.
Histologic Growth Patterns: Histologic growth pattern
at the boundary between the tumor and hepatic
parenchyma was classified into five types: sinusoi-
dal, replacement and encapsulated growth patterns,
which were described in hepatocellular carcinoma
by Nakashima et a/.,3)
expansive growth pattern
and unclassified pattern. The histologic features of
the individual growth patterns are as follows.
Sinusoidal growth pattern; tumor cells infiltrate into
the sinusoids at the boundary of the metastasis,
and liver cells are left inside the boundary of the
tumor. Replacement growth pattern; tumor cells
grow within the liver-cell plates, and replacing
tumor cells are in continuity with liver cells. In this
pattern, compression and destruction of the liver
cells close to the tumor cells are a little more
prominent than in the replacement growth pattern
in hepatocellular carcinoma. Expansive gorwth pat-
tern; tumor cells compress the liver-cell plates and
sinusoids and make the liver cells atrophic. In this
pattern, the border of the tumor is somewhat even
and smooth. Encapsulated growth pattern; metastat-
ic tumor foci have an enclosing fibrous capsule.
The correlation of the ratios of the individual
growth patterns and the sizes of the metastatic
tumors were evaluated at each primary site.
Results
Macroscopic Findings
Table II shows the ratios of the macroscopic
types of metastatic liver cancers. Massive type and
nodular type comprised 17 (17%) and 73 (73%)
cases, respectively. There were no cases showing the
diffuse type in the present study. Among nodular-
type metastases, there were 3 of the solitary type
(3%), 65 of the multinodular type (65%) and 5 of
the fused multinodular type (5%). The portal tract
type was seen in 8 cases (8%). In a case of pan-
creatic cancer and a case of uterine cancer,
metastases in the liver were invisible, macroscopical-
ly. Among all primary sites, the multinodular type
was most frequent. Primary sites of metastatic liver
cancers showing the portal tract type included 2
cases of pancreatic cancer, 2 cases of gastric cancer
and 4 cases of gallbladder/bile duct cancer. Four of
8 cases were poorly differentiated adenocarcinoma.
Microscopic Evaluation
Predominant Sites of Growth: Cases showing
predominant parenchymal growth were seen in
92.3% of colon cancers, 87.5% of lung cancers,
66.7% of pancreas cancers, 61.1% of stomach
25
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom
3. TERAYAMA ET AL.
Table II. Macroscopic Classification of Liver Metastases
Number (%) of cases
Primary site
Lung
Pancreas
Stomach
GB/Bile duct
Colon
Others
Number of
cases
24
21
17
14
13
10
Massive
type
0
3(14.3)
5(27.8)
4(28.6)
2(15.4)
3(30.0)
Solitary
0
0
1(5.6)
0
2(15.4)
0
Nodular type
Multiple
22(91.7)
15(71.4)
9(50.0)
6(42.8)
7(53.8)
6(60.0)
Fused multiple
2(8.3)
0
1(5.6)
0
2(15.4)
0
r
Total
24(100)
15(71.4)
11(61.2)
6(42.8)
11(84.6)
6(60.0)
Portal tract
type
0
2(9.5)
2(11.1)
4(28.6)
0
0
Invisible
type
0
1(4.8)
0
0
0
1(10.0)
GB, gallbladder. Diffuse type not found.
cancers, and 35.7% of gallbladder/bile duct
cancers. Among liver metastases from colon cancer
and lung cancer, the proportion of the cases show-
ing parenchymal growth was higher than that for
gallbladder/bile duct cancer (iJ
<0.05). On the other
hand, cases showing predominant portal tract
growth were seen in 35.7% of gallbladder/bile duct
cancers (Fig. 1), 19.0% of pancreas cancers, 16.7%
of stomach cancers, and 4.2% of lung cancers. In
the ramaining cases: 28.6% of gallbladder/bile duct
cancers, 22:2% of stomach cancers, 14.3% of pan-
creas cancers, 8.3% of lung cancers and 7.7% of
colon cancers, both parenchymal growth and por-
tal tract growth were seen equally.
Histoiogic Growth Patterns: In small metastases in
the liver less than 1 mm in diameter, a replacement
growth pattern (Fig. 2) was predominant for lung
cancer (69.7%), pancreas cancer (79.3%) and colon
cancer (66.7%). In these cases, the proportion
showing an expansive growth pattern increased as
the metastatic tumors grew. In metastases over
20 mm in diameter, an expansive growth pattern
(Fig. 3) was seen in 62.5%, 50.0% and 76.9%,
respectively. On the other hand, a sinusoidal
growth pattern (Fig. 4) was predominant in liver
metastases less than 1 mm in diameter from gastric
cancer and gallbladder/bile duct cancer (48.5% and
66.7%), followed by a replacement growth pattern
(39.4% and 26.7%, respectively). The proportion
showing an expansive growth pattern also increased
as the metastatic tumors grew. In these cases, an
expansive growth pattern was also predominant in
lesions over 20 mm in diameter (84.6% and
47.4%). Table III shows the proportions of the in-
dividual growth patterns.
A fibrous capsule around the metastatic liver
cancer was seen in two cases of colon cancer (Fig.
5) and two cases of renal cell cancer. Fibrous septa
in the metastasis were seen in two cases of colon
cancer and one case of small cell lung cancer. One
case of follicular carcinoma of the thyroid and
Fig. 1. Growth and spread of metastatic carcinoma of
the liver into the portal tract. Carcinoma cells are seen in por-
tal veins, lymphatic and connective tissue in the portal tract.
Metastasis from gallbladder cancer.
papillary carcinoma of the stomach showed a par-
tial fibrous capsule and fibrous septa. A case of
transitional cell carcinoma of the renal pelvis
showed microscopic intraductal growth.
Discussion
In this study, we classified macroscopically cases
of metastatic carcinoma of the liver resembling lym-
phangiosis carcinomatosa of the lung7>8)
as the
portal tract type. In such cases, tumor cells enter
the lymphatics in the portal tracts, spread to the in-
terstitium along the lymphatics, spread from the
hepatic hilum to the peripheral liver along the por-
tal tracts, and linear or small nodular tumors are
observed in the vicinity of the portal tracts.7
'8)
Poorly differentiated adenocarcinoma was most fre-
quent in the portal tract type. Particularly in gas-
tric cancer, pancreas cancer, and gallbladder/bile
duct cancer, the portal tract type was more fre-
quent than in other primary sites. With regard to
Jpn J Clin Oncol 26(1) 1996
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom
4. HISTOLOGIC GROWTH PATTERNS OF LIVER METASTASES
(a)
Fig. 2. Replacement growth pattern, metastasis from adenocarcinoma of the lung, (a) HE and (b) reticulin stain. Metastatic
carcinoma cells within liver-cell plates covered with reticulin fibers. M, metastasis.
Fig. 3. Expansive growth pattern, metastasis from colon cancer, (a) HE and (b) reticulin stain. Metastatic carcinoma
shows expansive growth. Liver-cell plates are compressed and atrophic. M, metastasis.
Fig. 4. Sinusoidal growth pattern, metastasis from colon cancer, (a) HE and (b) reticulin stain. Metastatic carcinoma
cells show intrasinusoidal growth and are present between liver-cell plates. M, metastasis.
27
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom
5. TERAYAMA ET AL.
Table
Primarv site
Lung
Pancreas
Stomach
GB/bile duct
Colon
III. Proportion of
Size of
metastasis (mm)
20 <
<20
< 3
< 1
20 s
<20
< 3
<I
20 <
<20
< 3
< 1
20 <
<20
< 3
< 1
20 <
<20
< 3
< 1
Five Types of
Replacing
31.3
18.9
40.4
69.7
25.0
37.5
60.0
79.3
0
22.2
23.5
39.4
15.8
31.6
28.0
26.7
7.7
7.7
12.5
66.7
Growth Patterns in
Proportion
Expansive
62.5
75.7
51.1
10.6
50.0
40.6
34.3
0
84.6
59.3
52.9
6.1
47.4
36.8
28.0
6.7
76.9
84.6
75.0
6.7
Relation to
of growth
Sinusoidal
0
0
2.1
13.6
4.2
3.1
0
17.2
7.7
7.4
20.6
48.5
0
0
0
66.7
0
0
12.5
26.7
i Size of Metastatic
pattern (<%)
Encapsulated
6.3
0
0
0
0
0
0
0
0
0
0
0
10.5
0
0
0
15.4
0
0
0
Tumor
Unclassified
0
5.4
6.4
6.1
20.8
18.8
5.7
3.4
7.7
11.1
2.9
6.1
26.3
31.6
44.0
0
0
7.7
0
0
Fig. 5. Encapsulated growth pattern. A metastatic car-
cinoma from cancer is surrounded by a fibrous capssule.
the predominant sites of growth of metastatic liver
cancers, prominent portal tract growth abounded in
poorly differentiated adenocarcinoma, particularly
metastases from the stomach, pancreas and gall-
blaldder/bile duct. These macro- and microscopic
findings may be related to the anatomical relation-
ship between the primary sites and the liver, and
the tendency for the tumor cells to enter the lym-
phatic channels. It is considered that these findings
may be useful for helping to indicate the primary
site.
The present study demonstrated that a replace-
ment growth pattern was not rare in metastatic
liver cancers. Especially in those from the lung,
pancreas and colon, the smaller the size of the
metastatic tumor, the higher the frequency of a
replacement growth pattern. Compared with the
replacement growth of hepatocellular carcinoma
noted by Nakashima et a/.,3)
even the tumors grew
within the liver-cell plates, although destruction and
compression of hepatocytes were more prominent
than in hepatocellular carcinoma. In the cases of
gastric cancer and gallbladder/bile duct cancer, a
sinusoidal growth pattern was predominant in small
metastases. Similar to the other primary sites, the
proportion of the expansive growth pattern in-
creased as the size of the metastases increased. It is
suggested that metastatic liver cancers grow in the
liver-cell plates and/or sinusoids at first, then the
speed of growth exceeds the rate of hepatocyte
replacement by tumor cells or invasion of tumor
cells into the sinusoids. Otherwise, the size of the
metastatic tumor and growth pattern might be as-
sociated with the intensity of adhesion among
tumor cells. That is, tumor cells with strong adhe-
sion form large metastatic nodules and show expan-
sive growth, and those with weak adhesion form
small nodules and show a replacement growth
pattern.
Small metastatic liver cancers are supplied by sur-
rounding hepatic sinusoids, and as the metastatic
28 Jpn J Clin Oncol 26(1) 1996
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom
6. HISTOLOGIC GROWTH PATTERNS OF LIVER METASTASES
tumor grows, newly formed blood vessels supply
them.9)
That is, metastatic liver cancers showing a
replacement or sinusoidal growth pattern are possi-
bly supplied by sinusoidal blood flow. The switch-
ing of the blood supply to metastatic liver cancers
is thought to be closely related to the change in
proportion of the growth pattern at the metastasis
periphery. This seems to be one of the reasons why
the effect of arterial infusion or arterial chemoem-
bolization of metastatic liver cancer is limited.
A few cases of metastatic liver cancer showed a
fibrous capsule and fibrous septa, particularly in
those from colon cancer. Furthermore, microscop-
ic portal venous tumor thrombi were often seen in
metastatic liver cancers in the present study. Indeed,
these are known to be features of hepatocellular
carcinoma, although a few cases of metastatic liver
cancer can also show them.
References
1) Craig JR, Peters RL, Edmondson HA: Metastatic
tumors. In Tumors of the Liver and Intrahepatic Bile
Ducts, 2nd series, Hartmann WH, ed, AFIP,
Washington. p256-267, 1989
2) Eggel H: Uber des primare Carcinoma der Leber.
Beitr path Anat allg Path 30: 506-604, 1901
3) Nakashima T, Kojiro M, Kawano Y, Shirai F,
Takemoto N, Tomimatsu Y, Kawasaki H, Okuda K:
Histologic growth pattern of hepatocellular carcino-
ma: relationship to orcein (hepatitis B surface anti-
gen-positive cells in cancer tissue. Hum Pathol 13:
563-568, 1982
4) Lee MJ, Saini S, Compton CC, Malt RA: MR
demonstration of edema adjacent to a liver metasta-
sis: pathologic correlation: American Journal oj
Roentogenology 157: 499-501, 1991
5) Matsui O, Takashima T, Kadoya M, Suzuki M,
Hirose J, Kameyama T, Choto S, Konishi H, Ida M,
Yamaguchi A, Izumi R: Liver metastases from
colorectal cancers: detection with CT during arterial
portography. Radiology 165: 65-69, 1987
6) Outwater E, Tomaszewski JE, Daly JM, Kressel HY:
Hepatic colorectal metastases: correlation of MR im-
aging and pathologic appearance. Radiology 180:
327-332, 1991
7) Itoh T, Kanaoka M, Obara A,
Lymphangiosis carcinomatosa
Pathol Jpn 38: 751-758, 1988
8) Itoh T, Itoh H, Konishi J: Lymphangitic liver
metastasis: radiologic-pathologic correlations. J Corn-
put Assist Tomogr 15: 401-404, 1991
9) Strohmeyer T, Haugeberg G, Lierse W: Angioar-
chitecture and blood supply of micro- and macro-
metastases in human livers: an anatomic-pathological
investigation using injection-techniques. J Hepatol 4:
181-189, 1987
Furuta M, Itoh H:
of the liver. Ada
29
byguestonJuly6,2011jjco.oxfordjournals.orgDownloadedfrom